|
CADRE is a non-profit organization committed to reducing the burden of diabetes by providing health care professionals with scientific information and educational initiatives designed to translate research into effective clinical practice.
Diabetes Education from CADRE
-
Cases in Success - Web-based, interactive case studies offer self-directed learning about various therapeutic strategies for treating type 2 diabetes. Each strategy is developed through a series of 3 case studies. Þ New CME opportunity !
- CADRE's Current Diabetes Practice - The CADRE newsletter
The current issue discusses topics regarding pre-diabetes, including prevalence, diagnosis, and diet and lifestyle interventions.
Read archived issues.
- Self-monitoring of Blood Glucose
CADRE's diabetes slide kit on the importance of SMBG in achieving optimal glycemic control.
CADRE Partnership with Insulin
CADRE and Insulin are working together to expand access to diabetes education: CADRE material will appear in the journal, and the journal provides complimentary print subscriptions to CADRE members. Read the current issue of Insulin, and then e-mail us with your name and address—we’ll set up the subscription for you.
Funding for CADRE
CADRE's educational activities are funded from many sources, including Amylin Pharmaceuticals, Amylin-Lilly, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly & Company, GlaxoSmithKline, Johnson & Johnson, LifeScan, Merck & Co., Novartis, Novo Nordisk, Nutrition 21, Pfizer, and sanofi-aventis. |
